Difference between revisions of "Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5 (Q9396)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): J. Clin. Endocrinol. Metab., #quickstatements; #temporary_batch_1590006349955) |
(Created claim: Volume (P103): 87, #quickstatements; #temporary_batch_1590009084631) |
||
| Property / Volume | |||
| + | 87 | ||
| Property / Volume: 87 / rank | |||
| + | Normal rank | ||
Revision as of 21:16, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Ishigaki K, et al. J. Clin. Endocrinol. Metab. (2002) cited as Ref 133 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Ishigaki K
0 references
2002
0 references
J. Clin. Endocrinol. Metab.
0 references
87
0 references
